Generali Investments CEE’s Bristol-Myers Squibb BMY Stock Holding History

Generali Investments CEE’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Hold	17,900	–	–	0.05%	286
2026 Q1	$1.09M	Hold	17,900	–	–	0.06%	272
2025 Q4	$966K	Hold	17,900	–	–	0.07%	250
2025 Q3	$807K	Hold	17,900	–	–	0.06%	262
2025 Q2	$829K	Hold	17,900	–	–	0.07%	251
2025 Q1	$1.09M	Hold	17,900	–	–	0.1%	214
2024 Q4	$1.01M	Buy	+17,900	New	+$1M	0.1%	202

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Generali Investments CEE's BMY Position: Q2 2026 in Review

Generali Investments CEE held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 17,900 shares worth $1.03M. The position accounts for 0.05% of the portfolio, ranked #286.

Generali Investments CEE first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.09M in Q1 2025. 917 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Generali Investments CEE held 17,900 shares of Bristol-Myers Squibb worth $1.03M as of Q2 2026.
Generali Investments CEE left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.05% of Generali Investments CEE's portfolio in Q2 2026, its #286 holding.
Generali Investments CEE first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Generali Investments CEE's Bristol-Myers Squibb position peaked at $1.09M in Q1 2025.
917 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Generali Investments CEE's 13F filing for Q2 2026, filed 13 Jul 2026.